Morgan Stanley »

Seelos Therapeutics Inc Class Equity shares owned by Morgan Stanley

Quarter-by-quarter ownership of Seelos Therapeutics Inc Class Equity shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Seelos Therapeutics Inc Class Equity

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Inc Class Equity held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Inc Class Equity by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $13k 22k 0.60

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
UnitedHealth (UNH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Morgan Stanley

Top funds holding Seelos Therapeutics Inc Class Equity

AdvisorShares Investments
Wealth Effects
Morgan Stanley
Modera Wealth Management
Geode Capital Management
BlackRock
Tower Research Capital
Carmichael Hill & Associates
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading
Vermillion & White Wealth Management Group
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group

View all funds holding Seelos Therapeutics Inc Class Equity